Chemical Synthesis of Native ADP-Ribosylated Oligonucleotides Enables Analysis of DNA ADP-Ribosylation Hydrolase Specificity
文献类型:期刊论文
| 作者 | Tang, Li2,3,4; Lu, Yang5; van der Heijden, Femke L. A. M.1; Chen, Yanrong3,6; Jiang, Shuyan3,7; Meeuwenoord, Nico J.1; Liu, Lingxiao3,8; Yu, Zongxing3,8; Chen, Zhenrong2,3,4; Schuller, Marion5 |
| 刊名 | JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
![]() |
| 出版日期 | 2026-01-08 |
| 页码 | 13 |
| ISSN号 | 0002-7863 |
| DOI | 10.1021/jacs.5c17532 |
| 通讯作者 | Filippov, Dmitri V.(filippov@lic.leidenuniv.nl) ; Ahel, Ivan(ivan.ahel@path.ox.ac.uk) ; Liu, Qiang(liuqiang@simm.ac.cn) |
| 英文摘要 | ADP-ribosylation (ADPr) is a modification by which an ADP-ribose moiety is conjugated to different molecules by ADP-ribosyltransferases (ARTs) to control various cellular processes in organisms from all kingdoms of life. While traditionally considered primarily as a post-translational modification of proteins, recent evidence has demonstrated that ADPr of nucleic acids (DNA and RNA) has emerged as a widespread type of ADPr. However, the precise biological roles and underlying mechanisms remain elusive, largely due to the lack of ADP-ribosylated nucleic acid molecular tools. Inspired by the native thymidine modification sites of ADP-ribosylated DNA, we developed a synthetic method for the chemo- and stereoselective assembly of both anomers of ADP-ribosylated thymidine (T-ADPr). We further tailored our method to successfully synthesize ADP-ribosylated oligonucleotides with desired sequences via an automatic solid-phase synthesis. We used the synthetic ADPr substrates, including the ADP-ribosylated DNA sequence motif TCTC that is targeted by bacterial ARTs to control DNA replication or antiphage response, and showed the utility of newly developed tools to characterize the specificity and mechanism of action of different hydrolases in ADPr reversal. |
| WOS关键词 | PROTEIN ; TOXIN ; MONO(ADP-RIBOSYL)ATION ; PIERISIN-1 ; RNA |
| 资助项目 | Science and Technology Commission of Shanghai Municipality[22PJ1415600] ; Cancer Research UK[C35050/A22284] ; Nederlandse Organisatie voor Wetenschappelijk Onderzoek[OCENW.KLEIN.497] ; National Natural Science Foundation of China[22207114] ; Bureau of Frontier Sciences and Education, Chinese Academy of Sciences[XDB1360000] ; Wellcome Trust[210634] ; Zhongshan Science and Technology Bureau[CXTD2022012] ; Biotechnology and Biological Sciences Research Council[BB/R007195/1] |
| WOS研究方向 | Chemistry |
| 语种 | 英语 |
| WOS记录号 | WOS:001656965000001 |
| 出版者 | AMER CHEMICAL SOC |
| 源URL | [http://119.78.100.183/handle/2S10ELR8/322560] ![]() |
| 专题 | 中国科学院上海药物研究所 |
| 通讯作者 | Filippov, Dmitri V.; Ahel, Ivan; Liu, Qiang |
| 作者单位 | 1.Leiden Univ, Leiden Inst Chem, Bioorgan Synth, NL-2300 RA Leiden, Netherlands 2.Chinese Acad Sci, Shanghai Inst Mat Med, Carbohydrate Based Drug Res Ctr, Shanghai 201203, Peoples R China 3.Zhongshan Inst Drug Discovery, Zhongshan 528400, Peoples R China 4.Univ Chinese Acad Sci, Beijing 100049, Peoples R China 5.Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England 6.Guangzhou Univ Chinese Med, Guangzhou 510006, Peoples R China 7.Nanjing Univ Chinese Med, Sch Chinese Mat Med, Nanjing 210023, Peoples R China 8.Southern Med Univ, Sch Pharmaceut Sci, Guangzhou 510515, Peoples R China |
| 推荐引用方式 GB/T 7714 | Tang, Li,Lu, Yang,van der Heijden, Femke L. A. M.,et al. Chemical Synthesis of Native ADP-Ribosylated Oligonucleotides Enables Analysis of DNA ADP-Ribosylation Hydrolase Specificity[J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY,2026:13. |
| APA | Tang, Li.,Lu, Yang.,van der Heijden, Femke L. A. M..,Chen, Yanrong.,Jiang, Shuyan.,...&Liu, Qiang.(2026).Chemical Synthesis of Native ADP-Ribosylated Oligonucleotides Enables Analysis of DNA ADP-Ribosylation Hydrolase Specificity.JOURNAL OF THE AMERICAN CHEMICAL SOCIETY,13. |
| MLA | Tang, Li,et al."Chemical Synthesis of Native ADP-Ribosylated Oligonucleotides Enables Analysis of DNA ADP-Ribosylation Hydrolase Specificity".JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2026):13. |
入库方式: OAI收割
来源:上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。

